Blood cancers

Moving mountains for a molehill of patients with follicular lymphoma

Sponsored by Roche Products Pty Ltd

Follicular lymphoma (FL) is the most common indolent lymphoma where a majority of patients have a favourable outlook with the median survival approaching 20 years. However, for a small subset of patients with early progression or refractory disease, the 5-year overall survival (OS) is remarkably poor. The limbic spoke with Professor John Seymour, Director of ...

Already a member?

Login to keep reading.

© 2021 the limbic